# FDA 483 - PPD Development, L.P. - July 12, 2021

Source: https://www.keypedia.com/records/483/ppd-development-lp/ccfcb620-b78a-4d74-bd5f-0ac42cce65eb

> FDA 483 for PPD Development, L.P. on July 12, 2021. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: PPD Development, L.P.
- Inspection Date: 2021-07-12
- Product Type: drugs
- Office Name: Minneapolis District Office
- Summary: An FDA inspection of PPD Development, LP's Control Testing Laboratory in Middleton, WI, revealed significant deficiencies in microbiological control. Observations included analysts not following aseptic techniques, inadequate media growth promotion procedures, and unvalidated environmental and personnel monitoring methods. These issues raise concerns about the integrity of microbial testing and potential contamination of test samples.

## Related Documents

- [483 - Unknown Date](https://www.keypedia.com/records/483/ppd-development-lp/61346431-fa4f-4c39-9544-0c075a540d6b)
- [483 - 2026-05-14](https://www.keypedia.com/records/483/ppd-development-lp/378f5be0-1030-40fb-b0fd-ea96e1302769)
- [EIR - 2021-07-16](https://www.keypedia.com/records/eir/ppd-development-lp/f8eac3b9-7684-413c-8dba-fe6d849d482a)
- [483 - 2023-04-05](https://www.keypedia.com/records/483/ppd-development-lp/199ff82e-a934-4fac-9fec-faa0405a7238)
- [483 - 2025-09-25](https://www.keypedia.com/records/483/ppd-development-lp/e2239a11-ea51-47a5-b646-89e4ea475acb)

## Related Officers

- [Eileen A. Liu](https://www.keypedia.com/people/eileen-a-liu/fa051db4-1242-4181-9af9-5b3cd2de5689)

Company: https://www.keypedia.com/companies/ppd-development-lp/0d495b78-4879-42fc-8887-4e0294e69720

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d